TrialSignal transduction and targeted therapy2025

Consolidative nivolumab versus observation in unresectable stage III non-small cell lung cancer patients following neoadjuvant nivolumab plus chemotherapy and concurrent chemoradiotherapy (CA209-7AL): a randomized clinical trial.

Bo Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.